Viking Therapeutics, Inc. (VKTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$32.51
Day's range
$33.8

Viking Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 6.88 M $223.88 M   4.06% 5.95%
FMR LLC 05/15/2026 6.02 M $196.05 M   -8.13% 5.21%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 5.01 M $163.11 M   100.00% 4.34%
05/08/2026 4.46 M $145.27 M   100.00% 3.86%
TWO SIGMA INVESTMENTS, LP 05/15/2026 4.43 M $144.22 M   81.96% 3.84%
STATE STREET CORP 05/15/2026 4.40 M $143.03 M   -1.12% 3.80%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 3.16 M $102.76 M   6.01% 2.73%
MORGAN STANLEY 05/15/2026 3.01 M $98.07 M   -2.03% 2.61%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.08 M $67.77 M   4.39% 1.80%
AMERICAN CENTURY COMPANIES INC 05/15/2026 2.08 M $67.64 M   580.68% 1.80%
RAYMOND JAMES FINANCIAL INC 05/14/2026 2.08 M $113.51 M   125.10% 1.80%
AMERIPRISE FINANCIAL INC 07/17/2026 1.68 M $54.63 M   25.36% 1.47%
D. E. SHAW & CO., INC. 05/15/2026 1.68 M $54.56 M   -2.43% 1.45%
UBS GROUP AG 05/05/2026 1.35 M $43.85 M   44.13% 1.17%
CITADEL ADVISORS LLC 05/15/2026 1.26 M $41.07 M   -27.14% 1.09%
GOLDMAN SACHS GROUP INC 05/15/2026 960.57 K $31.26 M   15.36% 0.83%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 956.50 K $31.12 M   -38.56% 0.83%
CITADEL ADVISORS LLC 05/15/2026 924.60 K $30.09 M   -35.59% 0.80%
VESTAL POINT CAPITAL, LP 05/15/2026 914.15 K $29.75 M   100.00% 0.79%
JANE STREET GROUP, LLC 05/12/2026 748.95 K $24.37 M   -50.11% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 736.47 K $23.96 M   5.17% 0.64%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 710.41 K $23.12 M   100.00% 0.61%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 705.81 K $22.97 M   -50.43% 0.61%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 696.30 K $22.66 M   -7.50% 0.60%
DIADEMA PARTNERS LP 05/15/2026 659.20 K $21.45 M   -4.31% 0.57%
BLACKBARN CAPITAL PARTNERS LP 05/15/2026 621.45 K $20.22 M   12.99% 0.54%
NORTHERN TRUST CORP 05/14/2026 573.28 K $18.65 M   5.96% 0.50%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 542.52 K $17.65 M   18.05% 0.47%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 540.50 K $17.59 M   -45.55% 0.47%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 525.48 K $17.10 M   2.29% 0.45%
DIADEMA PARTNERS LP 05/15/2026 525.18 K $17.09 M   55.91% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 516.11 K $16.79 M   -0.52% 0.45%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 500.00 K $16.27 M   0.00% 0.43%
JPMORGAN CHASE & CO 05/13/2026 485.70 K $14.53 M   -11.18% 0.42%
BANK OF NEW YORK MELLON CORP 05/05/2026 454.06 K $14.78 M   -4.33% 0.39%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 444.78 K $14.47 M   -0.01% 0.38%
CITADEL ADVISORS LLC 05/15/2026 428.30 K $13.94 M   -54.22% 0.37%
ROYAL BANK OF CANADA 05/15/2026 397.97 K $12.95 M   -12.61% 0.34%
FIRST WASHINGTON CORP 05/14/2026 385.37 K $12.54 M   -0.56% 0.33%
BLAIR WILLIAM & CO/IL 05/08/2026 371.12 K $12.08 M   -12.46% 0.32%
WALLEYE TRADING LLC 05/11/2026 363.70 K $11.83 M   -6.70% 0.31%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2026 358.66 K $11.67 M   86.45% 0.31%
CONCURRENT INVESTMENT ADVISORS, LLC 04/21/2026 347.79 K $11.32 M   23.74% 0.30%
STIFEL FINANCIAL CORP 05/12/2026 340.52 K $11.08 M   1.10% 0.29%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 05/08/2026 338.25 K $11.01 M   6.95% 0.29%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2026 332.19 K $10.81 M   41.01% 0.29%
BANK OF AMERICA CORP /DE/ 05/18/2026 330.72 K $10.76 M   -4.59% 0.29%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 330.10 K $10.74 M   0.00% 0.29%
WASATCH ADVISORS LP 04/21/2026 313.16 K $10.19 M   89.33% 0.27%
CAPTION MANAGEMENT, LLC 05/15/2026 305.00 K $9.92 M   38.01% 0.26%

Viking Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 540 institutional investors and hedge funds held shares of Viking Therapeutics Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 682,909

PRINCIPAL FINANCIAL GROUP INC: 494,509

Bank of New York Mellon Corp: 407,840

WASATCH ADVISORS LP: 312,767

Concurrent Investment Advisors, LLC: 306,280

CITIGROUP INC: 293,126

63.34% of Viking Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 86.08 M shares in the last 24 months. This purchase volume represents approximately $2.89 B in transactions.